콘텐츠로 건너뛰기
Merck
  • Early-life stress induces EAAC1 expression reduction and attention-deficit and depressive behaviors in adolescent rats.

Early-life stress induces EAAC1 expression reduction and attention-deficit and depressive behaviors in adolescent rats.

Cell death discovery (2020-08-21)
Han-Byeol Kim, Ji-Young Yoo, Seung-Yeon Yoo, San Won Suh, Seoul Lee, Ji Hye Park, Jun-Ho Lee, Tai-Kyoung Baik, Hye-Sun Kim, Ran-Sook Woo
초록

Neonatal maternal separation (NMS), as an early-life stress (ELS), is a risk factor to develop emotional disorders. However, the exact mechanisms remain to be defined. In the present study, we investigated the mechanisms involved in developing emotional disorders caused by NMS. First, we confirmed that NMS provoked impulsive behavior, orienting and nonselective attention-deficit, abnormal grooming, and depressive-like behaviors in adolescence. Excitatory amino acid carrier 1 (EAAC1) is an excitatory amino acid transporter expressed specifically by neurons and is the route for the neuronal uptake of glutamate/aspartate/cysteine. Compared with that in the normal control group, EAAC1 expression was remarkably reduced in the ventral hippocampus and cerebral cortex in the NMS group. Additionally, EAAC1 expression was reduced in parvalbumin-positive hippocampal GABAergic neurons in the NMS group. We also found that EAAC1-knockout (EAAC1-/-) mice exhibited impulsive-like, nonselective attention-deficit, and depressive-like behaviors compared with WT mice in adolescence, characteristics similar to those of the NMS behavior phenotype. Taken together, our results revealed that ELS induced a reduction in EAAC1 expression, suggesting that reduced EAAC1 expression is involved in the pathophysiology of attention-deficit and depressive behaviors in adolescence caused by NMS.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
Anti-Glutamate Transporter Antibody, neuronal, clone 4D6.2, clone 4D6.2, Chemicon®, from mouse
Sigma-Aldrich
Monoclonal Anti-Glutamic Acid Decarboxylase 65 antibody produced in mouse, clone GAD-6, purified immunoglobulin, buffered aqueous solution